Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Mayo Clinic, Rochester200 1st St SW |
Principal Investigator: |
Thanh P. Ho, MM |
|---|---|
Contact: |
Jordan Meyers Primary Site Coordinator (507) 293-2333 meyers.jordan2@mayo.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Mayo Clinic, Rochester Website: |
http://clinicaltrials.mayo.edu/dspSubthemes.cfm?theme_id=3 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.